Status:
COMPLETED
Assessment Of Peri-papillary Retinal Nerve Fiber Layer Thickness In Patients With Unilateral Branch Retinal Vein Occlusion
Lead Sponsor:
Al-Azhar University
Conditions:
Branch Retinal Vein Occlusion
Eligibility:
All Genders
47-68 years
Phase:
NA
Brief Summary
Several studies have indicated a relation between the development of RVO and elevated intraocular pressure (IOP) and glaucoma \[9\]. Further investigations into the structural alterations in the fello...
Eligibility Criteria
Inclusion
- patients with unilateral BRVO
Exclusion
- History of retinal and/or optic nerve diseases involving glaucomatous optic disc, ischemic optic neuropathy, or optic neuritis.
- History of trauma, intravitreal injections, vitreoretinal surgeries, and retinal or macular lasers.
- A significant media opacity that makes it difficult to capture clear images.
- No history of diabetes and/or hypertension in those recruited as the control group
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06146309
Start Date
December 1 2020
End Date
August 1 2022
Last Update
November 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Akram Fekry Elgazzar
Damietta, Egypt, 34517